Skip to main content
Log in

Increased bleeding risk with enoxaparin venothromboembolism prophylaxis compared with heparin in patients undergoing bariatric surgery

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Perioperative venothromboembolism (VTE) chemoprophylaxis is an established tenant of bariatric surgery; however, there is little comparative data to guide medication choice. The objective of this study was to determine if a change in VTE prophylaxis from heparin to enoxaparin was associated with differing rates of postoperative bleeding and VTE occurrence after bariatric surgery.

Methods

This retrospective cohort study included patients 18 years or older who underwent primary bariatric surgery (sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB)) at a single institution between March 2012 and December 2021. Subcutaneous unfractionated heparin was utilized for VTE prophylaxis from March 2012 through February 2018 and then enoxaparin was used from March 2018 through December 2021. Postoperative bleeding was defined as requiring a blood transfusion or reoperation for bleeding within 30 days of surgery. Chi-square test was used to test for differences between groups.

Results

There were 2159 patients who underwent bariatric surgery with 1324 (61.3%) patients in the heparin group and 835 (38.7%) in the enoxaparin group. Overall, 1,503 (69.6%) patients underwent SG and 656 (30.4%) RYGB. There was no difference in the ratio of SG to RYGB between the heparin and enoxaparin groups. Most patients were female (n = 1709, 79.2%) with a median age of 43.2 years (interquartile range (IQR): 35.6–52.2), and median BMI of 44.9 (IQR: 40.9–50.5). Overall postoperative bleeding occurred more frequently in the enoxaparin group (n = 26, 3.1%) compared with the heparin group (n = 12, 0.9%) (p < 0.01). Additionally, reoperation for bleeding was more frequent with enoxaparin (enoxaparin 0.8% vs. heparin 0.2%, p = 0.04). There was no difference in VTE occurrence between the two groups (heparin: n = 14, 1.1%, enoxaparin: n = 7, 0.8% (p = 0.61)).

Conclusions

An institutional change from heparin to enoxaparin for bariatric surgery perioperative VTE prophylaxis was associated with a significant increase in postoperative bleeding, with no difference in VTE complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Becattini C, Agnelli G, Manina G, Noya G, Rondelli F (2012) Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. Surg Obes Relat Dis 8(1):108–115. https://doi.org/10.1016/J.SOARD.2011.09.005

    Article  PubMed  Google Scholar 

  2. Imberti D, Baldini E, Pierfranceschi MG et al (2014) Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX study). Obes Surg 24(2):284–291. https://doi.org/10.1007/S11695-013-1105-X

    Article  PubMed  Google Scholar 

  3. Aminian A, Andalib A, Khorgami Z et al (2017) Who should get extended thromboprophylaxis after bariatric surgery?: A risk assessment tool to guide indications for post-discharge pharmacoprophylaxis. Ann Surg 265(1):143–150. https://doi.org/10.1097/SLA.0000000000001686

    Article  PubMed  Google Scholar 

  4. Finks JF, English WJ, Carlin AM et al (2012) Predicting risk for venous thromboembolism with bariatric surgery: results from the michigan bariatric surgery collaborative. Ann Surg 255(6):1100–1104. https://doi.org/10.1097/SLA.0B013E31825659D4

    Article  PubMed  Google Scholar 

  5. Nimeri AA, Bautista J, Ibrahim M et al (2018) Mandatory risk assessment reduces venous thromboembolism in bariatric surgery patients. Obes Surg 28(2):541–547. https://doi.org/10.1007/S11695-017-2909-X

    Article  PubMed  Google Scholar 

  6. Kruk ME, Pereira C, Vaz F, Bergstrom S, Galea S (2007) Economic evaluation of surgically trained assistant medical officers in performing major obstetric surgery in Mozambique. BJOG 114(10):1253–1260

    Article  CAS  PubMed  Google Scholar 

  7. Birkmeyer NJO, Finks JF, Carlin AM et al (2012) Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery. Arch Surg 147(11):994–998. https://doi.org/10.1001/ARCHSURG.2012.2298

    Article  PubMed  Google Scholar 

  8. Mukherjee D, Lidor AO, Chu KM, Gearhart SL, Haut ER, Chang DC (2008) Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations. J Gastrointest Surg 12(11):2015–2022. https://doi.org/10.1007/S11605-008-0600-1

    Article  PubMed  Google Scholar 

  9. Sapala JA, Wood MH, Schuhknecht MP, Sapala MA (2003) Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg 13(6):819–825. https://doi.org/10.1381/096089203322618588

    Article  PubMed  Google Scholar 

  10. Morino M, Toppino M, Forestieri P, Angrisani L, Allaix ME, Scopinaro N (2007) Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry. Ann Surg 246(6):1002–1007. https://doi.org/10.1097/SLA.0B013E31815C404E

    Article  PubMed  Google Scholar 

  11. Hamad GG, Bergqvist D (2007) Venous thromboembolism in bariatric surgery patients: an update of risk and prevention. Surg Obes Relat Dis 3(1):97–102. https://doi.org/10.1016/J.SOARD.2006.10.002

    Article  PubMed  Google Scholar 

  12. Brethauer SA (2013) ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis 9(4):493–497. https://doi.org/10.1016/J.SOARD.2013.03.006

    Article  Google Scholar 

  13. Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: american college of chest physicians evidence-based clinical practice guidelines (8TH Edition). Chest 133(6):381S-453S. https://doi.org/10.1378/CHEST.08-0656

    Article  CAS  PubMed  Google Scholar 

  14. Mehran A, Szomstein S, Zundel N, Rosenthal R (2003) Management of acute bleeding after laparoscopic Roux-en-Y gastric bypass. Obes Surg 6:842–847

    Article  Google Scholar 

  15. Amanda Dick T, Byrne K, Baker M, Budak A, Morgan K (2010) Gastrointestinal bleeding after gastric bypass surgery: nuisance or catastrophe? Surg Obes Relat Dis. 6:643–647

    Article  PubMed  Google Scholar 

  16. Nielsen AW, Helm MC, Kindel T et al (2017) Perioperative bleeding and blood transfusion are major risk factors for venous thromboembolism following bariatric surgery. Surg Endosc 5:2488–2495

    Google Scholar 

  17. Li A, Eshaghpour A, Tseng E et al (2021) Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more. Thromb Res 198:1–6

    Article  CAS  PubMed  Google Scholar 

  18. Singh K, Podolsky ER, Um S et al (2012) Evaluating the safety and efficacy of BMI-based preoperative administration of low-molecular-weight heparin in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes Surg 22(1):47–51. https://doi.org/10.1007/S11695-011-0397-Y

    Article  PubMed  Google Scholar 

  19. Fecso AB, Samuel T, Elnahas A et al (2018) Clinical indicators of postoperative bleeding in bariatric surgery. Surg Laparosc Endosc Percutan Tech 1:52–55

    Article  Google Scholar 

  20. Bakhos C, Alkhoury F, Kyriakides T, Reinhold R, Nadzam G (2009) Early postoperative hemorrhage after open and laparoscopic roux-en-y gastric bypass. Obes Surg 19(2):153–157. https://doi.org/10.1007/S11695-008-9580-1/TABLES/2

    Article  PubMed  Google Scholar 

  21. Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program | ACS. Accessed February 9, 2023. https://www.facs.org/quality-programs/accreditation-and-verification/metabolic-and-bariatric-surgery-accreditation-and-quality-improvement-program/

  22. Northwestern Medicine Enterprise Data Warehouse (NMEDW): Research: Feinberg School of Medicine: Northwestern University. Accessed March 16, 2023. https://www.feinberg.northwestern.edu/research/cores/units/edw.html

  23. Kothari SN, Lambert PJ, Mathiason MA (2007) A comparison of thromboembolic and bleeding events following laparoscopic gastric bypass in patients treated with prophylactic regimens of unfractionated heparin or enoxaparin. Am J Surg. 194(6):709–711

    Article  CAS  PubMed  Google Scholar 

  24. Scholten DJ, Hoedema RM, Scholten SE (2002) A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 12(1):19–24. https://doi.org/10.1381/096089202321144522

    Article  PubMed  Google Scholar 

  25. Kalfarentzos F, Stavropoulou F, Yarmenitis S et al (2001) Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Obes Surg 11(6):670–676. https://doi.org/10.1381/09608920160558588

    Article  CAS  PubMed  Google Scholar 

  26. Brotman DJ, Shihab HM, Prakasa KR et al (2013) pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: a systematic review and meta-analysis. JAMA Surg 148(7):675–686. https://doi.org/10.1001/JAMASURG.2013.72

    Article  CAS  PubMed  Google Scholar 

  27. Chang CK, Higgins RM, Rein L, Peppard WJ, Herrmann DJ, Kindel T (2023) Effectiveness of body mass index-based prophylactic enoxaparin dosing in bariatric surgery patients. J Surg Res 287:168–175. https://doi.org/10.1016/J.JSS.2023.01.018

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Author AJR is supported on a training grant by the National Cancer Institute. Surgical Multispecialty Access to Research in Residency Training (SMART) training grant [R38 CA245095].

Funding

Not applicable

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ezra N. Teitelbaum.

Ethics declarations

Disclosure

None related to this project. Audra J. Reiter: Intuitive Surgical, one-time honorarium. Alexander P. Nagle: Baxter. Eric S. Hungness: Intuitive, Baxter, Boston Scientific, Olympus, Ethicon. Ezra N. Teitelbaum: Boston Scientific Education and Consulting. Joanne Prinz and Yan Li: none.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reiter, A.J., Prinz, J., Li, Y. et al. Increased bleeding risk with enoxaparin venothromboembolism prophylaxis compared with heparin in patients undergoing bariatric surgery. Surg Endosc 37, 6983–6988 (2023). https://doi.org/10.1007/s00464-023-10219-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-023-10219-2

Keywords

Navigation